Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV000650639 | SCV000772486 | uncertain significance | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-12 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 933 of the KCNT1 protein (p.Arg933Cys). This variant is present in population databases (rs150395210, gnomAD 0.005%). This missense change has been observed in individuals with clinical features of KCNT1-related conditions (PMID: 36117860; Invitae). ClinVar contains an entry for this variant (Variation ID: 540571). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNT1 protein function with a negative predictive value of 80%. This variant disrupts the p.Arg933 amino acid residue in KCNT1. Other variant(s) that disrupt this residue have been observed in individuals with KCNT1-related conditions (PMID: 27779742), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Revvity Omics, |
RCV003133461 | SCV003812015 | uncertain significance | not provided | 2022-04-07 | criteria provided, single submitter | clinical testing |